{"id":102786,"date":"2014-01-23T14:51:13","date_gmt":"2014-01-23T19:51:13","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/mass-eye-and-ear-physician-awarded-rpb-career-development-award.php"},"modified":"2014-01-23T14:51:13","modified_gmt":"2014-01-23T19:51:13","slug":"mass-eye-and-ear-physician-awarded-rpb-career-development-award","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medical-school\/mass-eye-and-ear-physician-awarded-rpb-career-development-award.php","title":{"rendered":"Mass. Eye and Ear physician awarded RPB Career Development Award"},"content":{"rendered":"<p><p>    PUBLIC RELEASE DATE:  <\/p>\n<p>    22-Jan-2014  <\/p>\n<p>    Contact: Mary Leach    <a href=\"mailto:Mary_Leach@meei.harvard.edu\">Mary_Leach@meei.harvard.edu<\/a>    617-573-4170    Massachusetts Eye and Ear    Infirmary<\/p>\n<p>    Boston (Jan. 22, 2014)  The Harvard Medical School (HMS)    Department of Ophthalmology has been granted a $250,000    Research to Prevent Blindness (RPB) Career Development Award to    support eye research conducted by Jason I. Comander, M.D.,    Ph.D. The support will be provided over a four-year period.  <\/p>\n<p>    The RPB Career Development Award Fund was established in 1990    to attract young physicians and basic scientists to eye    research. To date, the program has given awards to 174 vision    research scientists in departments of ophthalmology at    universities across the country.  <\/p>\n<p>    Dr. Comander's current research efforts are focused on studying    patients with inherited retinal degenerations, including    retinitis pigmentosa (RP), which is caused by genetic mutations    inherited from one or both parents. Most people who suffer from    RP typically experience a steady visual decline during their    lifetime, with many patients becoming blind. The disease    affects approximately 100,000 people in the U.S. and 2 million    people worldwide.  <\/p>\n<p>    A clinician scientist, Dr. Comander is a member of the Retina    Service and the Berman-Gund Laboratory for the Study of Retinal    Degenerations at Mass. Eye and Ear. He also conducts research    as a member of the Ocular Genomics Institute at Mass. Eye and    Ear\/Harvard Medical School. With support from the RPB grant,    Dr. Comander intends to develop and apply techniques for    high-throughput functional characterization of human genetic    variation and mutation in retinitis pigmentosa.  <\/p>\n<p>    \"This research addresses a major challenge in understanding the    mechanisms that underlie the pathology of inherited retinal    disease, and will help us determine which gene misspellings in    patients are disease-causing and which are benign,\" says Dr.    Comander. \"This is an important time in the field of inherited    retinal degenerations, when early successes with gene therapy    and molecular diagnostics need to be expanded and translated    into broad clinical use.\"  <\/p>\n<p>    ###  <\/p>\n<p>    About Mass. Eye and Ear  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>The rest is here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2014-01\/meae-mea012214.php\" title=\"Mass. Eye and Ear physician awarded RPB Career Development Award\">Mass. Eye and Ear physician awarded RPB Career Development Award<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PUBLIC RELEASE DATE: 22-Jan-2014 Contact: Mary Leach <a href=\"mailto:Mary_Leach@meei.harvard.edu\">Mary_Leach@meei.harvard.edu<\/a> 617-573-4170 Massachusetts Eye and Ear Infirmary Boston (Jan. 22, 2014) The Harvard Medical School (HMS) Department of Ophthalmology has been granted a $250,000 Research to Prevent Blindness (RPB) Career Development Award to support eye research conducted by Jason I. Comander, M.D., Ph.D.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medical-school\/mass-eye-and-ear-physician-awarded-rpb-career-development-award.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[36],"tags":[],"class_list":["post-102786","post","type-post","status-publish","format-standard","hentry","category-medical-school"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/102786"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=102786"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/102786\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=102786"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=102786"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=102786"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}